ePicept.com
About ePicept.com
EpiCept is a specialty pharmaceutical company that focuses on fulfilling unmet medical needs in cancer treatment and pain management. The Company possesses an approved cancer product and a deep and balanced pipeline of three major clinical product candidates, including:EpiCept NP-1, a pain medication that has completed Phase II clinical trials.Crinobulin, an apoptosis inducer for solid vascularized tumors that is currently in Phase I clinical trials.
